September 23, 2008
Inovio Awarded US Army Contract for Bio-Defense Vaccine Research Using its Electroporation Delivery Technology
September 14, 2008
Inovio Biomedical Achieves 75% Complete Response Rate in Preclinical Testing of DNA-Based Cancer Vaccine Using Its Electroporation DNA Delivery System
Modern Mucosal Vaccines, Adjuvants & Microbicides 2008 October 22-24, 2008
Porto, Portugal
BIOCOM – Investor Conference
October 26-28, 2008
San Diego, CA
Automatically receive Inovio news and other updates by e-mail as soon as it is released. Sign up in the Investor Relations section.
Sign Up Now »
